Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AstraZeneca
AstraZeneca
Could Moderna and AstraZeneca's mRNA Heart Failure Drug Candidate Be a Winner?
Motley Fool
Sun, 12/5/21 - 10:47 pm
Moderna Therapeutics
AstraZeneca
AZD-8601
heart failure
MRNA
Researchers move closer to deciphering blood clots from AstraZeneca, J&J's Covid-19 vaccines
Endpoints
Fri, 12/3/21 - 10:57 am
JNJ
AstraZeneca
blood clots
vaccines
COVID-19
AstraZeneca blocks investor group's $7.6B buyout of rare disease specialist Sobi: report
Fierce Pharma
Fri, 12/3/21 - 10:45 am
AstraZeneca
Alexion
Sobi
M&A
AstraZeneca to Scrap Plan for U.S. Covid Booster Study
Bloomberg
Thu, 12/2/21 - 11:00 pm
AstraZeneca
vaccines
COVID-19
boosters
clinical trials
FDA grants priority review to AstraZeneca’s sNDA for breast cancer therapy
Pharmaceutical Business Review
Wed, 12/1/21 - 10:21 am
FDA
AstraZeneca
Lynparza
BRCA-mutant breast cancer
AstraZeneca opens new advance therapeutics R&D facility in Cambridge
Biopharma Reporter
Tue, 11/23/21 - 10:03 am
AstraZeneca
Cambridge
UK
R&D
Passive vaccination? AstraZeneca spotlights six-month protection with Covid-19 antibody among vulnerable group
Endpoints
Thu, 11/18/21 - 10:44 am
AstraZeneca
COVID-19
antibodies
passive vaccination
Moderna, AstraZeneca announce positive AZD8601 data from Phase 2 study in heart failure
Seeking Alpha
Mon, 11/15/21 - 12:27 pm
Moderna Therapeutics
MRNA
AstraZeneca
clinical trials
heart failure
AstraZeneca expects 'modest profitability' for next round of Covid-19 vaccine supply deals — and prunes pipeline in Q3 update
Endpoints
Fri, 11/12/21 - 11:38 am
AstraZeneca
earnings
vaccines
COVID-19
AstraZeneca wields ax, scrapping midphase programs from $1B takeover, Heptares pact in latest quarterly cull
Fierce Biotech
Fri, 11/12/21 - 10:41 am
AstraZeneca
Ardea Biosciences
Zuraampic
oncology
diabetes
AstraZeneca, FibroGen hope to keep their roxadustat dream alive with new FDA meeting
Fierce Pharma
Wed, 11/10/21 - 10:42 am
FibroGen
AstraZeneca
anemia
roxadustat
FDA
Judge overturns $2.4M whistleblower retaliation verdict against AstraZeneca
Fierce Pharma
Tue, 11/9/21 - 11:41 pm
AstraZeneca
legal
retaliation claims
whistleblowers
AstraZeneca Will Unite Vaccines, Antibody Therapies in New Division
BioSpace
Tue, 11/9/21 - 11:39 pm
AstraZeneca
vaccines
antibodies
GSK pulls off clean sweep of endpoint hits in anemia phase 3, positioning it to leapfrog AstraZeneca
Fierce Biotech
Mon, 11/8/21 - 10:47 am
GSK
chronic kidney disease
cliincal trials
FDA
AstraZeneca
anemia
erythropoietin
FibroGen
These Clinical Results Are Good News for AstraZeneca
Motley Fool
Sun, 11/7/21 - 10:52 pm
AstraZeneca
Imfinizi
biliary tract cancer
clinical trials
Judge rules HHS' letter enforcing 340B discounts was 'arbitrary'
Beckers Hospital Review
Tue, 11/2/21 - 11:51 pm
HHS
drug pricing
340B
AstraZeneca
Eli Lilly
Novo Nordisk
Sanofi
United Therapeutics
AstraZeneca Purges Two Respiratory Medicines in Big Day for Covis
BioSpace
Mon, 11/1/21 - 11:17 pm
AstraZeneca
COPD
Covis Pharma
Respiratory
Feeling Collaborative, Merck Inks Three More Deals to Strengthen Portfolio
BioSpace
Tue, 10/26/21 - 12:01 am
Merck
Keytruda
Xeris Biopharma
XeriJect
Evaxion Biotech
EVX-01
Daiichi Sankyo
AstraZeneca
datopotamab deruxtecan
AZ’s Imfinzi is first immunotherapy to raise survival in biliary tract cancer
Pharmaforum
Mon, 10/25/21 - 11:10 am
AstraZeneca
Imfinzi
biliary tract cancer
clinical trials
AstraZeneca veteran takes up CEO post at Medivir, becoming 4th person to hold the post in quick succession
Fierce Biotech
Mon, 10/25/21 - 10:50 am
Pharma CEOs
Medivir
AstraZeneca
Jens Lindberg
Pages
« first
‹ previous
…
22
23
24
25
26
27
28
29
30
…
next ›
last »